The present invention provides compositions and stable liquid formulationscomprising alpha adrenergic receptor antagonists and use therof for increasingblood flow. In one embodiment, the stable liquid formulations of thisinvention are useful for reversing the effects of an anesthetic agent,preferably a long-lasting local anesthetic agent administered in conjunctionwith an alpha adrenergic receptor agonist.